CA19-9 antibody product blog
Tags: Antibody; CA19-9; CA19-9 antibody;
The NCAD cdh2 (Catalog #MBS438959) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The N-Cadherin/Cadherin-2/CD325 (NCAD) reacts with Human, Mouse. Others not known. and may cross-react with other species as described in the data sheet. MyBioSource\'s N-Cadherin/Cadherin-2/CD325 (NCAD) can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunofluorescence (IF), Western Blot (WB), Immunohistochemistry (IHC) Formalin.FC/FACS: 0.5-1ug/million cells
IF: 1-2ug/ml
WB: 0.5-1.0ug/ml
IHC-F: 0.5-1.0ug/ml for 30 minutes at RT; Staining of formalin-fixed tissues requires boiling tissue sections in 10mM Tis with1mM EDTA, pH 9.0, for 10-20 min followed by cooling at RT for 20 minutes. Researchers should empirically determine the suitability of the NCAD cdh2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The NCAD cdh2 product has the following accession number(s) (GI #815890961) (NCBI Accession #NP_001295105.1) (Uniprot Accession #P19022). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Recombinant human N-cadherin extracellular domain
Cellular Localization: Cell Surface. Hu-chromosome Location: 18q11.2
Positive Control: HeLa or HUVEC cells. Heart, Pancreas or Cerebral Cortex. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing NCAD are readily searchable from our website. Different antibodies against the same target such as NCAD may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Breast Neoplasms, Cardiovascular Diseases, Disease Models, Animal, Disease Progression, Liver Diseases, Lung Neoplasms, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Experimental, Prostatic Neoplasms are some of the diseases may be linked to N-Cadherin/Cadherin-2/CD325 (NCAD). Bone, Brain, Embryonic Tissue, Eye, Heart, Liver, Lung, Muscle, Prostate, Vascular tissues are correlated with this protein. NCAD also interacts with the following gene(s): CTNNA1, CTNNB1, CTNND1, FGFR1, GJA1, LRP5, MMP9.